Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop, MD, Fop van Kooten, MD, Hans AJM Kuijsten, MD, Jelis Boiten, MD, Robert J van Oostenbrugge, MD, Rustam Al-Shahi Salman, PhD, Pablo M Lavados, MD, Gabriel JE Rinkel, MD, Walter M van den Bergh, MD and on behalf of the MASH-2 study group The Lancet Volume 380, Issue 9836, Pages 44-49 (July 2012) DOI: 10.1016/S0140-6736(12)60724-7 Copyright © 2012 Elsevier Ltd Terms and Conditions
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop,
Apr 01, 2015
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial
Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop, MD, Fop van Kooten, MD, Hans AJM Kuijsten, MD, Jelis Boiten, MD, Robert J van Oostenbrugge, MD, Rustam Al-Shahi Salman, PhD, Pablo M Lavados, MD, Gabriel JE Rinkel, MD, Walter M
van den Bergh, MD and on behalf of the MASH-2 study group
The LancetVolume 380, Issue 9836, Pages 44-49 (July 2012)
DOI: 10.1016/S0140-6736(12)60724-7
Copyright © 2012 Elsevier Ltd Terms and Conditions
Figure 1
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
Figure 2
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
Figure 3
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
Figure 4
Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)
Terms and Conditions
Related Documents
